Four novel cyclolipopeptides, glycinocins A to D, were isolated from the fermentation broth of an unidentified terrestrial Actinomycete species. These compounds were separated and purified from the fermentation broth by 1-butanol extraction, followed by repeated reversed-
phase HPLC. Their structures were elucidated by spectroscopic and chemical degradation studies. The absolute configuration of the amino acid residues was determined using Marfey's methodology. The glycinocin antibiotics are structurally related to amphomycin that was originally reported as a linear lipopeptide with C-terminal diketopiperazine moiety. Our degradation study of the glycinocin antibiotics also yielded diketopiperazine-containing fragments, but these have been shown to be hydrolytic by-products generated by condensation of the pipecolinic acid and diamino propionic acid residues.
In the course of our ongoing search for antibacterial leads from microorganisms1), an unidentified terrestrial Actinomycete, designated AW998, was found to produce new lipopeptide antibiotics. Lipopeptides constitute a broad and well-known family of antibiotics2). In this paper, we report the isolation and structure determination of the glycinocin antibiotics (Figure 1 ), and provide additional evidence that this antibiotic family, typified by amphomycin, does contain a cyclic peptide core. Taxonomy and fermentation of the producing organism as well as the biological activity will be reported elsewhere.
Results and Discussion

Isolation
The glycinocin antibiotics were mainly present in the fermentation broth, although a small amount of material was also associated with the cell mass. The metabolites were recovered by extraction of the filtrate with n-butanol and by methanol treatment of the mycelial mass of the AW998 culture. The antibiotic activity was concentrated in the n-BuOH layer based on assay against Staphylococcus aureus. Both n-BuOH and MeOH extracts were fractionated by reversed phase HPLC and the peaks were detected by UV absorbance at 215nm. The antibiotics were eluted in the following sequence: glycinocins C (3), D (4), A (1), and B (2). All compounds were finally obtained as white amorphous powders after lyophilization. However, due to the broadened and poorly resolved signals in the 1H and 13C NMR spectra, it was not feasible to fully assign the structure by NMR. For example, it was extremely difficult to identify the pipecolic acid residue as a result of the severely overlapping methylene signals.
Partial Acid Hydrolysis
Glycinocin A (1) was subjected to hydrolytic conditions in 3N hydrochloric acid solution (MeOH-H2O=1:1) preparative HPLC using a linear gradient from 50% to 80% MeCN-0.1% TFA buffer to give a series of products eluting in order: I, II, III, and IV. The most polar fraction I was further purified using the same HPLC column with a weaker gradient of 5% to 25% MeCN-0.1% TFA buffer to yield the polar fragments: Ia, Ib, Ic, and Id (Figure 2 ). The front peak that contained the hydrolyzed glycine and aspartic acid residues was not characterized.
Spectroscopic analyses of the chemical degradation products led to identification of all the fragments. The polar fragments were identified to be a diketopiperazine consisting of Dap and Pip (Ia), a tetrapeptide Thr-Ile-ProDap (Ib), a tripeptide Thr-Ile-Pro (Ic) , and a pentapeptide with the Dap-Pip diketopiperazine as the C-terminal (Id).
All the non-polar fragments were found to contain the fatty acyl moiety, which was consistent with their lower reversed phase HPLC mobility. They were: Thr-Ile-Pro-Dap-Asp-FA (II), a succinimido derivative (III), and Asp-FA (IV). The structures of fragments Ia, Ic, and Ib secured the sequence of the larger fragment Id. The diketopiperazine terminus of Id appeared to support the previously reported linear Although the aminosuccinimide present in III was recognized as an artifact created during the hydrolysis5), the structure of III gave further support for the existence of the Glycinocin B (2) was isolated as an optically active off-white powder. Its molecular formula was established as C58H92N12O19 by high resolution FT-ICR mass spectrometry. It only differed from the molecular formula of glycinocin A by the gain of a CH2 unit. The 1H and 13C NMR spectra of 2 were nearly identical to those recorded for 1, indicating that the two compounds were closely related. MS/MS characterization of 2 revealed that it had the same amino acid residues and peptide sequence but a longer fatty chain. Partial acid hydrolysis of 2 led to isolation of the fatty acyl aspartic acid conjugate, homologous to IV, identified by MS and NMR data as N-(2-isohexadecenoyl) aspartic acid. Glycinocin C (3) is an optically active metabolite whose molecular formula was determined to be C56H88N12O19 by high resolution FT-ICR mass spectrometry, differing from the molecular formula of 1 by the lack of one CH2 unit. The MS-MS spectrum of 3 showed the identical fragmentation pattern as that of 1, revealing that it differed from 1 only in the fatty chain. Analysis of 3 using Marfey's method confirmed that it contained the same constituent amino acid residues. The nearly identical 1H and 13C NMR spectra of 3 to those recorded for 1 prompted the conclusion that compound 3 contained a 2-isotetradecenoyl moiety. This was in a good agreement with its shorter retention time on 
